Login / Signup

Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis.

Ioannis PantazopoulosGeorgios MavrovounisGeorgios DimeasNikolaos ZikosMaria PitsikouEleni RousogianniMaria MermiriAnastasia MichouMichalis SpanosChristos ManiotisAthanasios ChalkiasEleni LaouGeorgios ZakynthinosDimitrios ChatzisKonstantinos Gourgoulianis
Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2022)
Treatment with remdesivir may be associated with new-onset bradycardia in hospitalised patients with COVID-19. However, bradycardia is transient and is not associated with ICU admission and mortality.
Keyphrases